Randomized Controlled Trial Comparing Efficacy of Sorafenib Versus Sorafenib In Combination With Low Dose Cisplatin /Fluorouracil Hepatic Arterial InfUSion Chemotherapy in Patients With Advanced Hepatocellular Carcinoma

NCT01214343 Phase 3 UNKNOWN

The purpose of this study is to evaluate the efficacy of sorafenib in combination with low dose cisplatin /fluorouracil hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma.

Details

Lead sponsor	Ministry of Health, Labour and Welfare, Japan
Phase	Phase 3
Status	UNKNOWN
Enrolment	190
Start date	2010-10
Completion	2013-09

Conditions

• Advanced Hepatocellular Carcinoma
• Carcinoma
• Carcinoma, Hepatocellular
• Liver Neoplasms
• Neoplasms

Interventions

• Sorafenib with Low-dose FP
• Sorafenib

Primary outcomes

• Overall survival — Overall survival is defined as the time from randomization to death due to any cause

Countries

Japan